Does Aggressive Surgical Resection Improve Survival in Advanced Stage 3 and 4 Neuroblastoma? A Systematic Review and Meta-analysis

REFERENCES

• Ries LAG, Smith MA, Gurney JG. Cancer incidence and survival among children and adolescents: United States SEER program 1975–1995, National Cancer Institute, SEER Program. NIH Pub No 99-4649 Bethesda, MD: National Cancer Institute; 1999.
   Google Scholar
• Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362:2202–2211.
   PubMed Web of Science ®Google Scholar
• Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3:203–216.
   PubMed Web of Science ®Google Scholar
• Kiely E. A technique for excision of abdominal and pelvic neuroblastomas. Ann R Coll Surg Engl. 2007;89:342–348.
   Google Scholar
• Adkins ES, Sawin R, Gerbing RB, Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study. J Pediatr Surg. 2004;39:931–936.
   Google Scholar
• La Quaglia MP, Kushner BH, Su W, The impact of gross total resection on local control and survival in high-risk neuroblastoma. J Pediatr Surg. 2004;39:412–417.
   PubMed Web of Science ®Google Scholar
• Rich BS, McEvoy MP, Kelly NE, Resectability and operative morbidity after chemotherapy in neuroblastoma patients with encasement of major visceral arteries. J Pediatr Surg. 2011;46:103–107.
   Google Scholar
• Kubota M, Okuyama N, Hirayama Y, Mortality and morbidity of patients with neuroblastoma who survived for more than 10 years after treatment–Niigata Tumor Board Study. J Pediatr Surg. 2010;45:673–677.
   Google Scholar
• Kiely EM. The surgical challenge of neuroblastoma. J Pediatr Surg. 1994;29:128–133.
   Google Scholar
• Losty P, Quinn F, Breatnach F, Neuroblastoma–a surgical perspective. Eur J Surg Oncol. 1993;19:33–36.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339: b2535.
   PubMed Web of Science ®Google Scholar
• Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815–2834.
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD. Bias in location and selection of studies. BMJ. 1998;316:61–66.
   PubMed Web of Science ®Google Scholar
• Matsumura M, Atkinson JB, Hays DM, An evaluation of the role of surgery in metastatic neuroblastoma. J Pediatr Surg. 1988;23:448–453.
   PubMed Web of Science ®Google Scholar
• Tsuchida Y, Yokoyama J, Kaneko M, Therapeutic significance of surgery in advanced neuroblastoma: a report from the study group of Japan. J Pediatr Surg. 1992;27:616–622.
   Google Scholar
• Powis MR, Imeson JD, Holmes SJ. The effect of complete excision on stage III neuroblastoma: a report of the European Neuroblastoma Study Group. J Pediatr Surg. 1996;31:516–519.
   Google Scholar
• Kaneko M, Ohakawa H, Iwakawa M. Is extensive surgery required for treatment of advanced neuroblastoma? J Pediatr Surg. 1997;32:1616–1619.
   Google Scholar
• Castel V, Tovar JA, Costa E, The role of surgery in stage IV neuroblastoma. J Pediatr Surg. 2002;37:1574–1578.
   PubMed Web of Science ®Google Scholar
• von Schweinitz D, Hero D, Berthold F. The Impact of Surgical Radicality on Outcome in Childhood Neuroblastoma. Eur J Pediatr Surg 2002;12(6): 402–409
   Google Scholar
• McGregor LM, Rao BN, Davidoff AM, The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: the St. Jude Children's Research Hospital Experience. Cancer. 2005;104:2837–2846.
   Google Scholar
• Sultan I, Ghandour K, Al-Jumaily U, Local control of the primary tumor in metastatic neuroblastoma. Eur J Cancer. 2009;45:1728–1732.
   Google Scholar
• Salim A, Mullassery D, Pizer B, Neuroblastoma: a 20-year experience in a UK regional centre. Pediatr Blood Cancer. 2011;57:1254–1260.
   PubMedGoogle Scholar
• Simon T, Häberle B, Hero B, Role of Surgery in the Treatment of Patients with stage 4 neuroblastoma age 18 months or older at diagnosis. J Clin Oncol. 2013;31:752–758
   PubMed Web of Science ®Google Scholar
• Koop CE, Schnaufer L. The management of abdominal neuroblastoma. Cancer. 1975;35:905–909.
   PubMedGoogle Scholar
• Rosen EM, Cassady JR, Frantz CN, Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience. J Clin Oncol. 1984;2:719–732.
   PubMed Web of Science ®Google Scholar
• Haase GM, Wong KY, deLorimier AA, Improvement in survival after excision of primary tumor in stage III neuroblastoma. J Pediatr Surg. 1989;24:194–200.
   Google Scholar
• Carlsen NL, Christensen IJ, Schroeder H, Prognostic factors in neuroblastomas treated in Denmark from 1943 to 1980. A statistical estimate of prognosis based on 253 cases. Cancer. 1986;58:2726–2735.
   PubMed Web of Science ®Google Scholar
• Haase GM, O'Leary MC, Ramsay NK, Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma. J Pediatr Surg. 1991;26:1119–1123.
   PubMed Web of Science ®Google Scholar
• Philip T, Zucker JM, Bernard JL, Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup? J Clin Oncol. 1991;9:1037–1044.
   PubMedGoogle Scholar
• Zucker JM, Philip T, Bernard JL, Single or double consolidation treatment according to remission status after initial therapy in metastatic neuroblastoma: first results of LMCE 3 study in 40 patients. Bone Marrow Transplant. 1991;7 Suppl 2:91.
   Google Scholar
• Shamberger RC, Allarde-Segundo A, Kozakewich HP, Surgical management of stage III and IV neuroblastoma: resection before or after chemotherapy? J Pediatr Surg. 1991;26:1113–1117.
   Google Scholar
• Berthold F, Trechow R, Utsch S, Prognostic factors in metastatic neuroblastoma. A multivariate analysis of 182 cases. Am J Pediatr Hematol Oncol. 1992;14:207–215.
   PubMedGoogle Scholar
• Garaventa A, De Bernardi B, Pianca C, Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma. J Clin Oncol. 1993;11:1770–1779.
   Google Scholar
• La Quaglia MP, Kushner BH, Heller G, Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome. J Pediatr Surg. 1994;29:1162–1165.
   PubMed Web of Science ®Google Scholar
• Chamberlain RS, Quinones R, Dinndorf P, Complete surgical resection combined with aggressive adjuvant chemotherapy and bone marrow transplantation prolongs survival in children with advanced neuroblastoma. Ann Surg Oncol. 1995;2:93–100.
   Google Scholar
• Le Tourneau JN, Bernard JL, Hendren WH, Evaluation of the role of surgery in 130 patients with neuroblastoma. J Pediatr Surg. 1985;20:244–249.
   PubMed Web of Science ®Google Scholar
• O'Neill JA, Littman P, Blitzer P, The role of surgery in localized neuroblastoma. J Pediatr Surg. 1985;20:708–712.
   Google Scholar
• DeCou JM, Bowman LC, Rao BN, Infants with metastatic neuroblastoma have improved survival with resection of the primary tumor. J Pediatr Surg. 1995;30:937–940.
   Google Scholar
• Shorter NA, Davidoff AM, Evans AE, The role of surgery in the management of stage IV neuroblastoma: a single institution study. Med Pediatr Oncol. 1995;24:287–291.
   Google Scholar
• Strother D, van Hoff J, Rao PV, Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumor resection: results from the Pediatric Oncology Group. Eur J Cancer. 1997;33:2121–2125.
   Google Scholar
• Matthay KK, Perez C, Seeger RC, Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study. J Clin Oncol. 1998;16:1256–1264.
   PubMed Web of Science ®Google Scholar
• Castel V, Cañete A, Navarro S, Outcome of high-risk neuroblastoma using a dose intensity approach: improvement in initial but not in long-term results. Med Pediatr Oncol. 2001;37:537–542.
   PubMedGoogle Scholar
• Haas-Kogan DA, Swift PS, Selch M, Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study. Int J Radiat Oncol Biol Phys. 2003;56:28–39.
   PubMedGoogle Scholar
• Koh CC, Sheu JC, Liang DC, Complete surgical resection plus chemotherapy prolongs survival in children with stage 4 neuroblastoma. Pediatr Surg Int. 2005;21:69–72.
   Google Scholar
• von Allmen D, Grupp S, Diller L, Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant. J Pediatr Surg. 2005;40:936–941.
   Google Scholar
• Hsu WM, Jen YM, Lee H, The influence of biologic factors on the surgical decision in advanced neuroblastoma. Ann Surg Oncol. 2006;13:238–244.
   Google Scholar
• Moon SB, Park KW, Jung SE, Neuroblastoma: treatment outcome after incomplete resection of primary tumors. Pediatr Surg Int. 2009;25:789–793.
   Google Scholar
• De Bernardi B, Gerrard M, Boni L, Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification. J Clin Oncol. 2009;27:1034–1040.
   PubMed Web of Science ®Google Scholar
• Modak S, Kushner BH, LaQuaglia MP, Management and outcome of stage 3 neuroblastoma. Eur J Cancer. 2009;45:90–98.
   Google Scholar
• Canete A, Gerrard M, Rubie H, Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Pediatric Oncology European Neuroblastoma Experience. J Clin Oncol. 2009;27:1014–1019.
   PubMed Web of Science ®Google Scholar
• Park JR, Villablanca JG, London WB, Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group. Pediatr Blood Cancer.2009;52:44–52.
   PubMed Web of Science ®Google Scholar
• Baker DL, Schmidt ML, Cohn SL, et al. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N Engl J Med. 2010;363:1313–1323.
   PubMed Web of Science ®Google Scholar
• Warmann SW, Seitz G, Schaefer JF, Vascular encasement as element of risk stratification in abdominal neuroblastoma. Surg Oncol. 2011;20:231–235.
   Google Scholar
• Rubie H, De Bernardi B, Gerrard M, Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1. J Clin Oncol. 2011;29:449–455.
   PubMedGoogle Scholar
• Li K, Dong K, Gao J, Neuroblastoma management in chinese children. J Invest Surg. 2012;25:86–92.
   PubMed Web of Science ®Google Scholar
• Tajiri T, Souzaki R, Kinoshita Y, Implications of surgical intervention in the treatment of neuroblastomas: 20-year experience of a single institution. Surg Today. 2012;42:220–224.
   Google Scholar
• Tan C, Sabai SM, Tin AS, Neuroblastoma: experience from National University Health System, Singapore (1987–2008). Singapore Med J. 2012;53:19–25.
   Google Scholar
• Koivusalo AI, Pakarinen MP, Rintala RJ, Saarinen-Pihkala UM. Surgical treatment of neuroblastoma: twenty-three years of experience at a single institution. Surg Today. 2014;44:517–525
   Google Scholar